Ruilong Sheng

Dr. Ruilong Sheng

Centro de Química da Madeira, Universidade da Madeira, 9000-390 Funchal, Madeira Islands, Portugal
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2012 in Biomaterials
Verified
Journal Article
Closed access
YSYuebin Shan
Yuebin Shan
TLTing Luo
Ting Luo
CPChen Peng
Chen Peng
RSRuilong Sheng
Ruilong Sheng
ACAmin Cao
Amin Cao
Xiangyang ShiXiangyang Shi
Xiangyang Shi

15 October 2008 in Organic Letters
Verified
Journal Article
Closed access
RSRuilong Sheng
Ruilong Sheng
PWPengfei Wang
Pengfei Wang
YGYunhua Gao
Yunhua Gao
YWYan Wu
Yan Wu
WLWeimin Liu
Weimin Liu
SWShikang Wu
Shikang Wu

17 August 2007 in Organic Letters
Verified
Journal Article
Closed access
WLWeimin Liu
Weimin Liu
LXLiwei Xu
Liwei Xu
RSRuilong Sheng
Ruilong Sheng
PWPengfei Wang
Pengfei Wang
HLHuaping Li
Huaping Li
SWShikang Wu
Shikang Wu

27 October 2022 in Analytical Chemistry
Verified
Journal Article
Closed access
HYHuan Ye
Huan Ye
SKSeyoung Koo
Seyoung Koo
BZBeitong Zhu
Beitong Zhu
YKYingjun Ke
Yingjun Ke
RSRuilong Sheng
Ruilong Sheng
Jong Seung KimJong Seung Kim
Jong Seung Kim

1 October 2021 in Bioactive Materials
Verified
Journal Article
Open access
YZYujun Zeng
Yujun Zeng
YXYufan Xiang
Yufan Xiang
RSRuilong Sheng
Ruilong Sheng
HTHelena Tomás
Helena Tomás
João RodriguesJoão Rodrigues
João Rodrigues
KLKui Luo
Kui Luo
Cancer immunotherapy is an effective antitumor approach through activating immune systems to eradicate tumors by immunotherapeutics. However, direct administration of “naked” immunotherapeutic agents (such as nucleic acids, cytokines, adjuvants or antigens without delivery vehicles) often results in: (1) an unsatisfactory efficacy due to suboptimal pharmacokinetics; (2) strong toxic and side effects due to low targeting (or off-target) efficiency. To overcome these shortcomings, a series of polysaccharide-based nanoparticles have been developed to carry immunotherapeutics to enhance antitumor immune responses with reduced toxicity and side effects. Polysaccharides are a family of natural polymers that hold unique physicochemical and biological properties, as they could interact with immune system to stimulate an enhanced immune response. Their structures offer versatility in synthesizing multifunctional nanocomposites, which could be chemically modified to achieve high stability and bioavailability for delivering therapeutics into tumor tissues. This review aims to highlight recent advances in polysaccharide-based nanomedicines for cancer immunotherapy and propose new perspectives on the use of polysaccharide-based immunotherapeutics.

1 April 2022 in Chemical Engineering Journal
Verified
Journal Article
Closed access
XYXingge Yu
Xingge Yu
XWXiuhui Wang
Xiuhui Wang
DLDejian Li
Dejian Li
RSRuilong Sheng
Ruilong Sheng
YQYifeng Qian
Yifeng Qian
Kaili LinKaili Lin
Kaili Lin